Gabriele Escherich

Oxford Road
Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 160 publications

Immunoglobulin Depletion and Recovery Following Blinatumomab in Infants With KMT2A-Rearranged ALL.

Immunoglobulin Depletion and Recovery Following Blinatumomab in Infants With KMT2A-Rearranged ALL.

Journal: Pediatric blood & cancer

Published: June 01, 2026

Sustained Benefit of Blinatumomab in Infants With KMT2A-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics.

Sustained Benefit of Blinatumomab in Infants With KMT2A-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 08, 2026

How important it is to feel self-efficacious - an exploratory analysis of pediatric and adolescent childhood cancer survivors during long-term follow-up care.

How important it is to feel self-efficacious - an exploratory analysis of pediatric and adolescent childhood cancer survivors during long-term follow-up care.

Journal: Journal of psychosocial oncology

Published: January 08, 2026

Dietary intervention among young cancer survivors within the CARE for CAYA program.

Dietary intervention among young cancer survivors within the CARE for CAYA program.

Journal: Journal of cancer survivorship : research and practice

Published: November 11, 2025

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study of 288 patients.

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study of 288 patients.

Journal: Blood advances

Published: October 03, 2025

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patients.

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patients.

Journal: Blood advances

Published: October 03, 2025

Characterization of a PRKCE::ETV6 fusion as a potential oncogenic driver in T-cell acute lymphoblastic leukemia.

Characterization of a PRKCE::ETV6 fusion as a potential oncogenic driver in T-cell acute lymphoblastic leukemia.

Journal: Molecular and cellular pediatrics

Published: August 08, 2025

Role of common host genome variants in Childhood Acute Lymphoblastic Leukemia.

Role of common host genome variants in Childhood Acute Lymphoblastic Leukemia.

Journal: Leukemia

Published: August 01, 2025

The psychosocial situation of parents of children with cancer during aftercare - Results of a qualitative study

The psychosocial situation of parents of children with cancer during aftercare - Results of a qualitative study

Journal: Psychotherapie, Psychosomatik, medizinische Psychologie

Published: April 01, 2025

A case report of a pediatric T-cell acute lymphoblastic leukemia with a subclonal GCC2::PDGFRB t(2;5) translocation - implementation for the selection of MRD-targets.

A case report of a pediatric T-cell acute lymphoblastic leukemia with a subclonal GCC2::PDGFRB t(2;5) translocation - implementation for the selection of MRD-targets.

Journal: Leukemia & lymphoma

Published: March 20, 2025

DNA-incorporated thioguanine to detect potential non-adherence to maintenance therapy in acute lymphoblastic leukemia.

DNA-incorporated thioguanine to detect potential non-adherence to maintenance therapy in acute lymphoblastic leukemia.

Journal: Cancer chemotherapy and pharmacology

Published: March 07, 2025

Childhood cancer survivors' struggle for social integration after treatment a mixed-methods exploration of activity and participation.

Childhood cancer survivors' struggle for social integration after treatment a mixed-methods exploration of activity and participation.

Journal: PloS one

Published: February 25, 2025

Showing 1-12 of 160

Last Updated: 09/26/2026